Q2 2026 Holdings
Filed 2026-08-14 | 89 holdings | $21.7B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| State STR Spdr S&P 500 ETF T(SPY)Put | TR UNIT | 78462F103 | $4.5B | 6,000,000 | 20.7% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $2.5B | 13,550,796 | 11.7% |
| Electronic Arts Inc(EA) | COM | 285512109 | $1.6B | 7,919,500 | 7.5% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $800.1M | 10,743,063 | 3.7% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $778.2M | 6,348,906 | 3.6% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $732.8M | 13,468,010 | 3.4% |
| Liquidia Corporation(LQDA) | COM NEW | 53635D202 | $666.9M | 8,365,038 | 3.1% |
| Amazon COM Inc(AMZN) | COM | 023135106 | $627.5M | 2,632,994 | 2.9% |
| Lantheus Hldgs Inc(LNTH) | COM | 516544103 | $619.4M | 5,583,479 | 2.9% |
| Natera Inc(NTRA) | COM | 632307104 | $602.2M | 2,218,366 | 2.8% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $528.1M | 1,270,532 | 2.4% |
| Thermo Fisher Scientific Inc(TMO) | COM | 883556102 | $526.0M | 1,049,185 | 2.4% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $506.4M | 14,309,000 | 2.3% |
| AON PLC(AON) | SHS CL A | G0403H108 | $458.6M | 1,382,562 | 2.1% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $449.0M | 10,521,184 | 2.1% |
| Broadcom Inc(AVGO) | COM | 11135F101 | $435.1M | 1,151,800 | 2.0% |
| Microsoft Corp(MSFT) | COM | 594918104 | $415.1M | 1,112,863 | 1.9% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $383.8M | 12,277,000 | 1.8% |
| KKR & Co Inc(KKR) | COM | 48251W104 | $378.0M | 4,118,300 | 1.7% |
| Synopsys Inc(SNPS) | COM | 871607107 | $370.1M | 829,600 | 1.7% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $351.3M | 10,236,396 | 1.6% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $336.4M | 8,989,098 | 1.6% |
| Grail Inc(GRAL) | COM | 384747101 | $284.1M | 4,161,584 | 1.3% |
| Wabtec(WAB) | COM | 929740108 | $241.2M | 894,503 | 1.1% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $223.7M | 5,805,000 | 1.0% |
| Twist Bioscience Corp(TWST) | COM | 90184D100 | $219.8M | 2,136,400 | 1.0% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $219.6M | 5,917,400 | 1.0% |
| Aramark(ARMK) | COM | 03852U106 | $206.3M | 3,625,731 | 1.0% |
| Baidu Inc(BIDUN) | SPON ADR REP A | 056752108 | $137.6M | 1,203,785 | 0.6% |
| Novo-Nordisk A S(NVO) | ADR | 670100205 | $125.6M | 2,619,000 | 0.6% |
| Acadia Healthcare Company in(ACHC) | COM | 00404A109 | $124.6M | 4,220,800 | 0.6% |
| Brightspring Health Svcs Inc(BTSG) | COM | 10950A106 | $120.8M | 1,732,800 | 0.6% |
| Astrazeneca PLC(AZN) | ORD | G0593M107 | $108.8M | 574,000 | 0.5% |
| Johnson & Johnson(JNJ) | COM | 478160104 | $103.6M | 408,000 | 0.5% |
| Ishares TR(SOXX)Put | ISHARES SEMICDTR | 464287523 | $83.3M | 130,000 | 0.4% |
| Strategy Inc | NOTE 12/0 | 594972AS0 | $75.4M | $87,858,000 | 0.3% |
| Parabilis Medicines Inc(PBLS) | COM | 698955101 | $64.8M | 2,368,200 | 0.3% |
| Novartis AG(NVSN) | SPONSORED ADR | 66987V109 | $56.9M | 363,000 | 0.3% |
| Guardant Health Inc(GH) | COM | 40131M109 | $48.3M | 322,200 | 0.2% |
| Vnet Group Inc | NOTE 2.000%10/0 | 90138AAE3 | $46.8M | $45,000,000 | 0.2% |
| Avalo Therapeutics Inc(AVTX) | COM NEW | 05338F306 | $46.2M | 2,498,000 | 0.2% |
| Joyy Inc(JOYY) | ADS REPSTG COM A | 46591M109 | $46.1M | 699,200 | 0.2% |
| Assembly Biosciences Inc(ASMB) | COM NEW | 045396207 | $44.1M | 1,604,590 | 0.2% |
| Enanta Pharmaceuticals Inc(ENTA) | COM | 29251M106 | $35.3M | 2,418,202 | 0.2% |
| Maze Therapeutics Inc(MAZE) | COM | 578784100 | $33.1M | 1,107,814 | 0.2% |
| CG Oncology Inc(CGON)Call | COM | 156944100 | $28.4M | 400,000 | 0.1% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $25.6M | 199,000 | 0.1% |
| Warby Parker Inc(WRBY) | CL A COM | 93403J106 | $25.1M | 828,000 | 0.1% |
| Perceptive Cap Solutions COR | CL A ORD SHS | G70077105 | $24.5M | 2,250,000 | 0.1% |
| Kailera Therapeutics Inc(KLRA) | COMMON STOCK | 482931102 | $24.2M | 1,100,000 | 0.1% |